하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.
하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
As we make our first steps in 2024, HIRONIC would like to extend wishes for success, prosperity, and health to its partners and their loved ones in the new year.
Reflecting on 2023, a year marked by challenges and exciting achievements, we invite you to recap major milestones of HIRONIC:
• Celebration
of the company's 17th anniversary by HIRONIC and its partners
• Presentation
of HIRONIC flagship products at IMCAS, DUBAI DERMA, COSMOPROF, AAD, KIMES, and
AMWC
• MFDS
certification for NEW DOUBLO 2.0™ (Korean trademark: V-RO ADVANCE™)
• Publication
of two scientific papers on the Synergy Dotting (MFU+RF)
technology
of
NEW DOUBLO™ in the Journal of Cosmetic Dermatology and the Skin Research &
Technology Journal
• Recognition
of GENTLO™ with an award for excellence in the Innovative Device category at the
Northern Ireland Cosmetic Medicine Awards
• Publication
of a clinical study involving Ultra Vera™ in the Journal of Obstetrics,
Gynecology, and Perinatology
• Launch
and successful conduct of HIRONIC Distributor Training four times for global
partners
• Increased
presence in Asia, South America, and Eastern Europe
• Receipt
of
the '2023 Customer Satisfaction Award,' securing the prize for the 6th
consecutive year
HIRONIC expresses gratitude to all its global partners for their continuous support and trust in the company's products, anticipating greater accomplishments in 2024.
HIRONIC Press Center
